Advancements in Biopharma: Innovations and Challenges

This chapter explores the iterative development of the DAISY platform and its role in enhancing healthcare outcomes, particularly concerning hepatitis delta and oncology. It discusses the hurdles faced by certain drugs in the approval process and the importance of strategic partnerships in advancing innovative treatments. The episode concludes with a focus on ongoing clinical trials and hopes for future developments in cancer therapies and viral infections.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app